AN2 Therapeutics Ownership | Who Owns AN2 Therapeutics?
AN2 Therapeutics Ownership Summary
AN2 Therapeutics is owned by 48.69% institutional investors, 19.69% insiders, and 31.62% retail investors. Bml capital management is the largest institutional shareholder, holding 19.27% of ANTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.49% of its assets in AN2 Therapeutics shares.
ANTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | AN2 Therapeutics | 48.69% | 19.69% | 31.62% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bml capital management | 5.75M | 19.27% | $7.93M |
| Citadel advisors | 1.55M | 5.22% | $3.34M |
| Almitas capital | 1.31M | 4.40% | $1.81M |
| Vanguard group | 1.04M | 3.47% | $1.43M |
| Pfizer | 715.29K | 2.40% | $987.11K |
| Renaissance | 579.77K | 1.94% | $800.09K |
| Two sigma advisers, lp | 528.30K | 1.77% | $729.05K |
| Bank of montreal /can/ | 422.08K | 1.41% | $582.47K |
| Two sigma investments, lp | 400.33K | 1.34% | $552.46K |
| Bank of nova scotia | 394.87K | 1.32% | $544.92K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 5.75M | 4.93% | $7.93M |
| Aldebaran capital | 343.68K | 0.45% | $474.28K |
| Almitas capital | 1.31M | 0.40% | $1.81M |
| Stonepine capital management | 196.73K | 0.22% | $271.49K |
| Pfizer | 715.29K | 0.04% | $987.11K |
| Bridgeway capital management | 162.20K | 0.01% | $223.84K |
| Xtx topco | 34.18K | 0.00% | $47.17K |
| Two sigma advisers, lp | 528.30K | 0.00% | $729.05K |
| Renaissance | 579.77K | 0.00% | $800.09K |
| Two sigma investments, lp | 400.33K | 0.00% | $552.46K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Almitas capital | 1.31M | 0.40% | 1.31M |
| Pfizer | 715.29K | 0.04% | 715.29K |
| Bank of montreal /can/ | 422.08K | 0.00% | 422.08K |
| Two sigma advisers, lp | 528.30K | 0.00% | 407.40K |
| Bank of nova scotia | 394.87K | 0.00% | 394.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -3.22M |
| Frazier life sciences management | - | - | -2.09M |
| Ra capital management | - | - | -2.00M |
| Tcg crossover management | - | - | -1.56M |
| Bvf inc/il | - | - | -1.24M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Almitas capital | 1.31M | 0.40% | 1.31M | $1.81M |
| Pfizer | 715.29K | 0.04% | 715.29K | $987.11K |
| Bank of montreal /can/ | 422.08K | 0.00% | 422.08K | $582.47K |
| Bank of nova scotia | 394.87K | 0.00% | 394.87K | $544.92K |
| Stonepine capital management | 196.73K | 0.22% | 196.73K | $271.49K |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -128.00 |
| Fmr | -300.00 |
| California state teachers retirement system | -9.25K |
| Clear street markets | -10.00K |
| Atom investors lp | -11.90K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 37 | 19.35% | 14,528,930 | 7.52% | 48 | 2.37% | 24 | 50.00% | 7 | - |
| Sep 30, 2024 | 31 | -31.11% | 13,513,224 | -30.40% | 45 | 1.06% | 16 | -20.00% | 7 | -46.15% |
| Jun 30, 2024 | 45 | -16.67% | 19,415,909 | 3.64% | 65 | 1.04% | 20 | -35.48% | 13 | -18.75% |
| Mar 31, 2024 | 54 | 5.88% | 18,733,564 | -8.13% | 79 | 1.26% | 31 | -3.13% | 16 | 60.00% |
| Dec 31, 2023 | 51 | 37.84% | 20,391,503 | 2.31% | 79 | 0.76% | 32 | 23.08% | 10 | 25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 749.42K | 2.49% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 261.93K | 0.87% | - |
| Bridgeway Ultra-Small Company Market | 161.30K | 0.54% | - |
| Fidelity Extended Market Index | 115.04K | 0.38% | -733.00 |
| iShares Micro-Cap ETF | 35.21K | 0.12% | - |
| BlackRock Extended Equity Market K | 33.77K | 0.11% | -14.00 |
| Bridgeway Ultra-Small Company | 33.20K | 0.11% | 33.20K |
| Extended Equity Market Fund K | 33.42K | 0.11% | 102.00 |
| Fidelity Total Market Index | 31.17K | 0.10% | - |
| Fidelity Series Total Market Index | 28.46K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 03, 2025 | Day Lucy | Chief Financial Officer | Sell | $3.97K |
| Jan 03, 2025 | Chanda Sanjay | Chief Development Officer | Sell | $3.97K |
| Jan 03, 2025 | Prior Stephen David | Chief Strategy Officer | Sell | $2.72K |
| Jan 03, 2025 | Eizen Joshua M | See Remarks | Sell | $12.96K |
| Dec 10, 2024 | Readnour Robin Shane | - | Buy | $7.46K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 4 |
| 2024 Q4 | 18 | - |
| 2024 Q3 | 1 | 2 |
| 2024 Q2 | - | - |
ANTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools